# NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors

> **NCT01324115** · PHASE1 · TERMINATED · sponsor: **Cancer Research UK** · enrollment: 6 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** NG-nitro-L-arginine
- **OTHER:** laboratory biomarker analysis
- **OTHER:** pharmacological study
- **PROCEDURE:** computed tomography
- **PROCEDURE:** dynamic contrast-enhanced magnetic resonance imaging

## Key facts

- **NCT ID:** NCT01324115
- **Lead sponsor:** Cancer Research UK
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-04
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Sponsor Decision
- **Last updated:** 2015-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01324115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01324115, "NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01324115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*